Temilolu Idowu
10PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Nov 07, 2024
Author Correction: Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases.Partho Protim Adhikary, Temilolu Idowu, Zheng Tan
|Jun 14, 2024
Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases.Partho Protim Adhikary, Temilolu Idowu, Zheng Tan
|Jan 08, 2020
A Dimer, but Not Monomer, of Tobramycin Potentiates Ceftolozane against Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa and Delays Resistance Development.Temilolu Idowu, George G Zhanel, Frank Schweizer
|Sep 27, 2019
Homodimeric Tobramycin Adjuvant Repurposes Novobiocin as an Effective Antibacterial Agent against Gram-Negative Bacteria.Temilolu Idowu, Derek Ammeter, Heather Rossong
|Aug 18, 2019
Development of a nebramine-cyclam conjugate as an antibacterial adjuvant to potentiate β-lactam antibiotics against multidrug-resistant P. aeruginosa.Derek Ammeter, Temilolu Idowu, George G Zhanel
|Mar 16, 2018
Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?Ronald Domalaon, Temilolu Idowu, George G Zhanel
Pageof 2
